Found: 6
Select item for more details and to access through your institution.
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 389, p. 1, doi. 10.1126/scitranslmed.aal2668
- By:
- Publication type:
- Article
The Chromatin Remodeling Factor CHD5 Is a Transcriptional Repressor of WEE1.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0108066
- By:
- Publication type:
- Article
Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair.
- Published in:
- Nature, 2015, v. 518, n. 7538, p. 258, doi. 10.1038/nature14184
- By:
- Publication type:
- Article
Human CHD1 is required for early DNA-damage signaling and is uniquely regulated by its N terminus.
- Published in:
- Nucleic Acids Research, 2018, v. 46, n. 8, p. 3892, doi. 10.1093/nar/gky128
- By:
- Publication type:
- Article
Annealing helicase HARP closes RPA-stabilized DNA bubbles non-processively.
- Published in:
- Nucleic Acids Research, 2017, v. 45, n. 8, p. 4687, doi. 10.1093/nar/gkx147
- By:
- Publication type:
- Article
Functional consequences of Rett syndrome mutations on human MeCP2.
- Published in:
- Nucleic Acids Research, 2000, v. 28, n. 21, p. 4172, doi. 10.1093/nar/28.21.4172
- By:
- Publication type:
- Article